Table 2 Positive subjects in relation to parameters analyzed
From: Assessment of a combination screening assay for celiac disease
Total cases | IgA a-tTGa | IgG a-tTGa | IgA EMAa | IgA a-DGPa | IgG a-DGPa | h-tTG/DGP Screena | |
|---|---|---|---|---|---|---|---|
CD patients | 41 | 41/41 | 32/41 | 41/41 | 37/41 | 36/41 | 41/41 |
100% | 78.04% | 100% | 90.24% | 87.80% | 100% | ||
CD patients on treatment with the gluten free-diet | 18 | 11/18 | 10/18 | 9/18 | 5/18 | 6/18 | 14/18 |
61.11% | 55.55% | 50.00% | 27.77% | 33.33% | 77.77% | ||
Disease controls | 145 | 2/145 | 29/145 | 0/145 | 5/145 | 7/145 | 14/145 |
1.37% | 20.00% | 0% | 3.44% | 4.82% | 9.65% | ||
Normal controls | 24 | 0/24 | 1/24 | 0/24 | 0/24 | 0/24 | 1/24 |
0% | 4.16% | 0% | 0% | 0% | 4.16% |